TREA

98084156 - EXPLORE44-OLE

Follow

Information

  • Trademark
  • 98084156
  • Serial Number
    98084156
  • Filing Date
    July 13, 2023
    a year ago
  • Transaction Date
    November 27, 2024
    2 months ago
  • Status Date
    July 30, 2024
    6 months ago
  • Published for Opposition Date
    June 04, 2024
    8 months ago
  • Location Date
    July 30, 2024
    6 months ago
  • Status Code
    688
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    FERRAIUOLO, DOMINIC
  • Attorney Docket Number
    45532-TM1014
    Attorney Name
    Aaron D. Hendelman
    Law Office Assigned Location Code
    L20
  • Owners
Information
Mark Drawing Code
4
Mark Identification
EXPLORE44-OLE
Case File Statements
  • GS0051: Antibodies for medical purposes comprising oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of viral diseases and disorders, endocrine diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, neuromuscular diseases and disorders, rare muscle diseases, cardiomyopathies diseases and disorders, heart muscle diseases, muscular dystrophies, muscle atrophy diseases and disorders, genitourinary diseases and disorders, sexual dysfunction, oncological diseases and disorders, hepatological diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, dermatological diseases and disorders and psychiatric diseases and disorders, none of the aforementioned offerings being in the nature of dietetic substances for medical use, foods for special medical purposes, or special nutritional food products for medical purposes
  • PM0001: EXPLORE FOUR FOUR OLE; EXPLORE FORTY FOUR OLE
  • GS0421: Medical and scientific research, namely, conducting clinical trials for others for oligonucleotide-based therapeutics in the fields of pharmaceuticals and biotechnology, namely, conducting clinical trials for the treatment of viral diseases and disorders, endocrine diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, neuromuscular diseases and disorders, rare muscle diseases, cardiomyopathies diseases and disorders, heart muscle diseases, muscular dystrophies, muscle atrophy diseases and disorders, genitourinary diseases and disorders, sexual dysfunction, oncological diseases and disorders, hepatological diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, dermatological diseases and disorders and psychiatric diseases and disorders; providing medical and scientific research information in the fields of pharmaceuticals and biotechnology; none of the aforementioned offerings being in the nature of dietetic substances for medical use, foods for special medical purposes, or special nutritional food products for medical purposes
Case File Event Statements
  • 7/17/2023 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 8/13/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/23/2024 - 11 months ago
    3 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 2/23/2024 - 11 months ago
    4 - TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Type: TAEA
  • 3/21/2024 - 10 months ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/26/2024 - 10 months ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/26/2024 - 10 months ago
    7 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/26/2024 - 10 months ago
    8 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/25/2024 - 9 months ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/25/2024 - 9 months ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/25/2024 - 9 months ago
    9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/1/2024 - 9 months ago
    12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/15/2024 - 8 months ago
    13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/4/2024 - 8 months ago
    15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/4/2024 - 8 months ago
    14 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/30/2024 - 6 months ago
    16 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 11/27/2024 - 2 months ago
    17 - TEAS STATEMENT OF USE RECEIVED Type: EISU